Previous 10 | Next 10 |
2024-04-23 11:26:33 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Remains The Better Buy After A Moderate Pullback Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly buys injectable medicine manufact...
2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...
2024-04-23 04:34:38 ET Summary VanEck Pharmaceutical ETF is a popular option for investors looking for exposure to leading pharmaceutical companies. The ETF has been in an uptrend since late last year and is currently trading at a level that presents a buying opportunity. The ...
2024-04-22 16:25:01 ET More on S&P 500 Index: Why AI Stocks Could Go Boom Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Nasdaq, S&P, an...
2024-04-22 13:25:00 ET Summary UBS sounded a warning on its list of Big 6 tech companies, cut rating on them to "Neutral". Tesla stock hits a new 52-week low after troubling developments on car pricing. Check out Goldman's picks top capex and R&D stocks. Listen b...
2024-04-22 10:20:45 ET Eli Lilly ( NYSE: LLY ) has agreed to acquire a manufacturing facility from Nexus Pharmaceuticals to further expand its global parenteral (injectable) product manufacturing network and support increased demand for its drugs.... Read the full article ...
2024-04-22 09:00:00 ET Summary NVO continues to be rated as a Buy, with the stock already charting an impressive +16.1% rally over the past three months, well outperforming the wider market at +4.8%. The management recently announced multiple expansions in its manufacturing/fill f...
(NewsDirect) Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of drugs was originally designed to manage blood sugar levels in diabetics but was...
2024-04-22 00:58:35 ET Summary The FDA has convened an advisory panel to discuss the safety and efficacy of Eli Lilly's anti-amyloid antibody drug donanemab. Approval of donanemab could have a modestly positive impact on LLY stock, while denial could lead to a substantial (but not...
2024-04-21 22:55:15 ET Summary The stock market has been experiencing unusual volatility in the past few weeks. High-flying stocks like Nvidia, Eli Lilly, and GE Aerospace have experienced significant sell-offs. Nvidia's recent drop may be due to concerns about its relationshi...
News, Short Squeeze, Breakout and More Instantly...
Eli Lilly and Company Company Name:
LLY Stock Symbol:
NYSE Market:
Lilly Declares Second-Quarter 2024 Dividend PR Newswire INDIANAPOLIS , May 6, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstandin...
2024-05-05 14:49:00 ET A company's track record for paying dividends is a good indicator of how versatile and adaptable the business is in dealing with changing economic conditions. That doesn't mean that the dividend will always be safe and that payouts will always continue, but it's an im...
2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...